U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 19

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:61731863
GRCh38:
Chr11:61964391
BEST1, FTH1Retinitis pigmentosa, Hemochromatosis type 5, Vitelliform macular dystrophy 2,
Autosomal dominant vitreoretinochoroidopathy
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
2.
GRCh37:
Chr11:61735033
GRCh38:
Chr11:61967561
FTH1Hemochromatosis type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
3.
GRCh37:
Chr11:61734911
GRCh38:
Chr11:61967439
FTH1Hemochromatosis type 5Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
4.
GRCh37:
Chr11:61734838
GRCh38:
Chr11:61967366
FTH1Hemochromatosis type 5Benign
(Mar 20, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr11:61732040
GRCh38:
Chr11:61964568
BEST1, FTH1Hemochromatosis type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr11:61735101
GRCh38:
Chr11:61967629
FTH1Hemochromatosis type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr11:61734899
GRCh38:
Chr11:61967427
FTH1Hemochromatosis type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr11:61732941
GRCh38:
Chr11:61965469
BEST1, FTH1K54RRetinitis Pigmentosa, Recessive, Hemochromatosis type 5, Autosomal dominant vitreoretinochoroidopathy,
Iron Overload, not provided, Vitelliform macular dystrophy 2
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr11:61732894
GRCh38:
Chr11:61965422
BEST1, FTH1Hemochromatosis type 5Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr11:61732447
GRCh38:
Chr11:61964975
BEST1, FTH1Retinitis Pigmentosa, Recessive, not provided, Hemochromatosis type 5,
Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2, Iron Overload
Benign/Likely benign
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr11:61732368
GRCh38:
Chr11:61964896
BEST1, FTH1Hemochromatosis type 5Benign
(Jan 13, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr11:61732338
GRCh38:
Chr11:61964866
BEST1, FTH1Y138FHemochromatosis type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr11:61732034
GRCh38:
Chr11:61964562
BEST1, FTH1Hemochromatosis type 5Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:61731977
GRCh38:
Chr11:61964505
BEST1, FTH1Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy, not provided,
Hemochromatosis type 5, Vitelliform macular dystrophy 2, Iron Overload
Benign
(May 10, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr11:61731887
GRCh38:
Chr11:61964415
BEST1, FTH1Retinitis pigmentosa, Autosomal dominant vitreoretinochoroidopathy, Hemochromatosis type 5,
Vitelliform macular dystrophy 2
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr11:61731880
GRCh38:
Chr11:61964408
BEST1, FTH1Retinitis Pigmentosa, Recessive, Retinitis pigmentosa, Autosomal dominant vitreoretinochoroidopathy,
Hemochromatosis type 5, not provided, Vitelliform macular dystrophy 2
Benign/Likely benign
(Aug 17, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr11:61731810
GRCh38:
Chr11:61964338
BEST1, FTH1Retinitis Pigmentosa, Recessive, Retinitis pigmentosa, not provided,
Hemochromatosis type 5, Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2
Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr11:61731803
GRCh38:
Chr11:61964331
BEST1, FTH1Retinitis Pigmentosa, Recessive, Retinitis pigmentosa, Hemochromatosis type 5,
Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr11:61735061
GRCh38:
Chr11:61967589
FTH1Hemochromatosis type 5Pathogenic
(Jul 1, 2001)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination